PL
PL · PL · PL-100177882
BeneFix
ATC B02BD04
Last synced from URPL (Poland) on
Identification
ManufacturerPfizer Europe MA EEIG
CountryPL (PL)
ATC codeB02BD04
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 1
- gtin05909990057184
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań",
"source": "urpl",
"strength": "250 j.m.",
"packaging": "05909990057184 ¦ Rpz ¦ EU/1/97/047/004 ¦ 36571\n1 fiol. 250 j.m. proszku ¦ 1 zestaw do wstrzykiwań ¦ 1 amp.-strzyk. 5 ml rozpuszczalnik",
"substance": "Rekombinowany czynnik krzepnięcia IX (nonacog alfa) 250 j.m.",
"common_name": "Nonacogum alfa. Czynnik IX krzepnięcia krwi ludzki rekombinowany",
"pl_product_id": "100177882",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code B02BD04.
- NOAlprolixSwedish Orphan Biovitrum International AB
- 🇨🇭Alprolix
- ISAlprolix*Swedish Orphan Biovitrum AB (publ)
- ISAlprolix*Swedish Orphan Biovitrum AB (publ)
- ISAlprolix*Swedish Orphan Biovitrum AB (publ)
- ISAlprolix*Swedish Orphan Biovitrum AB (publ)
- ISAlprolix*Swedish Orphan Biovitrum AB (publ)
- PLAlprolixSwedish Orphan Biovitrum AB
Access this data programmatically
Query BeneFix and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.